Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Outlook Therapeutics (OTLK) over the last 5 years, with Q4 2025 value amounting to -$0.38.

  • Outlook Therapeutics' EPS (Weighted Average and Diluted) changed N/A to -$0.38 in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.62, marking a year-over-year decrease of 6300.25%. This contributed to the annual value of -$1.79 for FY2025, which is 5581.24% up from last year.
  • Outlook Therapeutics' EPS (Weighted Average and Diluted) amounted to -$0.38 in Q4 2025.
  • In the past 5 years, Outlook Therapeutics' EPS (Weighted Average and Diluted) registered a high of -$0.38 during Q4 2025, and its lowest value of -$1.5 during Q1 2025.